Guishan Jin

Beijing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

HSV-1 induced autophagy-associated DPD degradation promotes antitumor efficacy of oncolytic HSV-CD/5-FC in experimental glioblastoma.

HSV-1 induced autophagy-associated DPD degradation promotes antitumor efficacy of oncolytic HSV-CD/5-FC in experimental glioblastoma.

Journal: Cellular signalling

Published: April 02, 2026

ON-01, an engineered recombinant oncolytic herpes simplex virus type-1, in recurrent glioma: A single-arm, phase 1/2 study.

ON-01, an engineered recombinant oncolytic herpes simplex virus type-1, in recurrent glioma: A single-arm, phase 1/2 study.

Journal: Neuro-oncology

Published: April 26, 2025

Fatty acid metabolic reprogramming in the tumor microenvironment: Unraveling mechanisms and therapeutic prospects.

Fatty acid metabolic reprogramming in the tumor microenvironment: Unraveling mechanisms and therapeutic prospects.

Journal: Genes & diseases

Published: March 03, 2025

Glioblastoma cells secrete ICAM1 via FASN signaling to promote glioma-associated macrophage infiltration.

Glioblastoma cells secrete ICAM1 via FASN signaling to promote glioma-associated macrophage infiltration.

Journal: Cellular signalling

Published: January 30, 2025

TS-2021, a third-generation oncolytic adenovirus that carried Ki67 promoter, TGF-β2 5'UTR, and IL-15 against experimental glioblastoma.

TS-2021, a third-generation oncolytic adenovirus that carried Ki67 promoter, TGF-β2 5'UTR, and IL-15 against experimental glioblastoma.

Journal: Journal of medical virology

Published: July 09, 2023

Ki67-targeted oncolytic adenovirus expressing IL-15 improves intratumoral T cell infiltration and PD-L1 expression in glioblastoma.

Ki67-targeted oncolytic adenovirus expressing IL-15 improves intratumoral T cell infiltration and PD-L1 expression in glioblastoma.

Journal: Virology

Published: May 05, 2023

Correction: HIF-α activation by the prolyl hydroxylase inhibitor roxadustat suppresses chemoresistant glioblastoma growth by inducing ferroptosis.

Correction: HIF-α activation by the prolyl hydroxylase inhibitor roxadustat suppresses chemoresistant glioblastoma growth by inducing ferroptosis.

Journal: Cell death & disease

Published: January 17, 2023

Oncolytic HSV-1 suppresses cell invasion through downregulating Sp1 in experimental glioblastoma.

Oncolytic HSV-1 suppresses cell invasion through downregulating Sp1 in experimental glioblastoma.

Journal: Cellular signalling

Published: November 01, 2022

Recruitment mechanisms and therapeutic implications of tumor-associated macrophages in the glioma microenvironment.

Recruitment mechanisms and therapeutic implications of tumor-associated macrophages in the glioma microenvironment.

Journal: Frontiers in immunology

Published: October 12, 2022

HIF-α activation by the prolyl hydroxylase inhibitor roxadustat suppresses chemoresistant glioblastoma growth by inducing ferroptosis.

HIF-α activation by the prolyl hydroxylase inhibitor roxadustat suppresses chemoresistant glioblastoma growth by inducing ferroptosis.

Journal: Cell death & disease

Published: April 19, 2022

P4HA1 Regulates CD31 via COL6A1 in the Transition of Glioblastoma Stem-Like Cells to Tumor Endothelioid Cells.

P4HA1 Regulates CD31 via COL6A1 in the Transition of Glioblastoma Stem-Like Cells to Tumor Endothelioid Cells.

Journal: Frontiers in oncology

Published: December 15, 2021

Glioma-associated mesenchymal stem cells-mediated PD-L1 expression is attenuated by Ad5-Ki67/IL-15 in GBM treatment.

Glioma-associated mesenchymal stem cells-mediated PD-L1 expression is attenuated by Ad5-Ki67/IL-15 in GBM treatment.

Journal: Stem cell research & therapy

Published: December 13, 2021

Showing 1-12 of 29

Last Updated: 09/26/2026